HomeInsightsStock Comparison

Alembic Pharmaceuticals Ltd vs Sotac Pharmaceuticals Ltd Stock Comparison

Alembic Pharmaceuticals Ltd vs Sotac Pharmaceuticals Ltd Stock Comparison

Last Updated on: Jul 16, 2025

Key Highlights

  • The Latest Trading Price of Alembic Pharmaceuticals Ltd is ₹ 1027 as of 16 Jul 13:51.
  • The P/E Ratio of Alembic Pharmaceuticals Ltd changed from 12.1 on March 2020 to 31.3 on March 2025 . This represents a CAGR of 17.16% over 6 yearsThe P/E Ratio of Sotac Pharmaceuticals Ltd changed from 31.3 on March 2024 to 0 on March 2025 . This represents a CAGR of -100.00% over 2 years.
  • The Market Cap of Alembic Pharmaceuticals Ltd changed from ₹ 10059 crore on March 2020 to ₹ 18265 crore on March 2025 . This represents a CAGR of 10.45% over 6 yearsThe Market Cap of Sotac Pharmaceuticals Ltd changed from ₹ 133.71 crore on March 2024 to ₹ 0 crore on March 2025 . This represents a CAGR of -100.00% over 2 years.
  • The revenue of Alembic Pharmaceuticals Ltd for the Mar '25 is ₹ 1783 crore as compare to the Dec '24 revenue of ₹ 1702 crore. This represent the growth of 4.77% The revenue of Sotac Pharmaceuticals Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0%.
  • The ebitda of Alembic Pharmaceuticals Ltd for the Mar '25 is ₹ 285.46 crore as compare to the Dec '24 ebitda of ₹ 270.08 crore. This represent the growth of 5.69% The ebitda of Sotac Pharmaceuticals Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0%.
  • The net profit of Alembic Pharmaceuticals Ltd changed from ₹ 120.6 crore to ₹ 156.63 crore over 8 quarters. This represents a CAGR of 13.96% The net profit of Sotac Pharmaceuticals Ltd changed from ₹ 0.98 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% .
  • The Dividend Payout of Alembic Pharmaceuticals Ltd changed from 19.45 % on March 2020 to 42.97 % on March 2025 . This represents a CAGR of 14.12% over 6 yearsThe Dividend Payout of Sotac Pharmaceuticals Ltd changed from 13.94 % on March 2022 to 0 % on March 2025 . This represents a CAGR of -100.00% over 4 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Alembic Pharmaceuticals Ltd

  • Alembic Pharmaceuticals Limited manufactures and markets generic pharmaceutical products all over the world.
  • The company's state of the art research and manufacturing facilities are approved by regulatory authorities of many developed countries including the US FDA. The company is one of the leaders in branded generics in India. Alembic Pharmaceuticals Limited was incorporated on June 16, 2010 as a wholly owned subsidiary of Alembic Limited.
  • The company is engaged in pharmaceuticals business.
  • As per the Scheme of Arrangement, the 'Pharmaceutical Undertaking' of Alembic Limited got demerged and transferred to the Company with effect from April 1, 2010. In April 2011, the company ceased to be a subsidiary of Alembic Ltd consequent to the allotment of 13,35,15,914 equity shares of Rs 2 each to the shareholders of Alembic Ltd as per the scheme of arrangement.

About Sotac Pharmaceuticals Ltd

  • Sotac Pharmaceuticals Limited was originally formed and registered as a Partnership Firm under the Partnership Act, 1932 in the name of 'M/s Sotac Pharmaceuticals', pursuant to a Deed of Partnership dated October 28, 2015.
  • Thereafter 'M/s.
  • Sotac Pharmaceuticals' was converted from Partnership Firm to a Private Limited Company in the name of 'Sotac Pharmaceuticals Private Limited' dated December 18, 2015 from the Assistant Registrar of Companies, Gujarat.
  • Later on, Company converted into a Public Limited Company and the name of Company was changed to 'Sotac Pharmaceuticals Limited' dated November 22, 2022 issued by Registrar of Companies, Ahmedabad. The Company is a part of SOTAC Group, based at Gujarat and is engaged in manufacturing of pharmaceutical products for different marketers on loan license or contract manufacturing basis.

Alembic Pharmaceuticals Ltd News Hub

News

Alembic Pharma appoints G. Krishnan as new CFO

Krishnan is a seasoned finance professional with over 22 years of experience across the ph...

Read more

07 Jul 2025 14:58

News

Alembic Pharmaceuticals announces acquisition of Utility Therapeutics

Alembic Pharmaceuticals Inc., wholly owned subsidiary of Alembic Pharmaceuticals has acqui...

Read more

03 Jul 2025 09:15

News

Alembic Pharma inks deal to acquire Utility Therapeutics for $12 million

Utility Therapeutics is involved in the development and approval of two brand pharmaceutic...

Read more

03 Jul 2025 10:40

News

Alembic Pharma jumps after receiving USFDA nod for Doxorubicin Hydrochloride Injection

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD)...

Read more

30 Jun 2025 10:12

News

Alembic Pharmaceuticals Ltd leads gainers in 'A' group

Jindal Worldwide Ltd, RattanIndia Power Ltd, AAVAS Financiers Ltd and Force Motors Ltd are...

Read more

30 Jun 2025 12:00

News

Volumes soar at Alembic Pharmaceuticals Ltd counter

Jyoti CNC Automation Ltd, Raymond Ltd, TBO Tek Ltd, Raymond Lifestyle Ltd are among the ot...

Read more

30 Jun 2025 14:30

Sotac Pharmaceuticals Ltd News Hub

News

Board of Sotac Pharmaceuticals recommends final dividend

Sotac Pharmaceuticals announced that the Board of Directors of the Company at its meeting ...

Read more

29 May 2025 11:12

News

Sotac Pharmaceuticals to convene board meeting

Sotac Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 28 M...

Read more

24 May 2025 20:10

News

Sotac Pharmaceuticals schedules board meeting

Sotac Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 29 O...

Read more

26 Oct 2024 10:22

News

Sotac Pharmaceuticals AGM scheduled

Sotac Pharmaceuticals announced that the 9th Annual General Meeting (AGM) of the company w...

Read more

30 Aug 2024 16:55

News

Sotac Pharmaceuticals to conduct board meeting

Sotac Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 A...

Read more

09 Aug 2024 16:36

News

Sotac Pharmaceuticals to conduct board meeting

Sotac Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 17 M...

Read more

10 May 2024 12:07

SWOT Analysis Of Alembic Pharmaceuticals Ltd

Strength

1

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Sotac Pharmaceuticals Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Alembic Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Sotac Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Alembic Pharmaceuticals Ltd and Sotac Pharmaceuticals Ltd

Which company has a larger market capitalization, Alembic Pharmaceuticals Ltd or Sotac Pharmaceuticals Ltd?

Market cap of Alembic Pharmaceuticals Ltd is 20,256 Cr while Market cap of Sotac Pharmaceuticals Ltd is 143 Cr

What are the key factors driving the stock performance of Alembic Pharmaceuticals Ltd and Sotac Pharmaceuticals Ltd?

The stock performance of Alembic Pharmaceuticals Ltd and Sotac Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Alembic Pharmaceuticals Ltd and Sotac Pharmaceuticals Ltd?

As of July 16, 2025, the Alembic Pharmaceuticals Ltd stock price is INR ₹1030.55. On the other hand, Sotac Pharmaceuticals Ltd stock price is INR ₹129.85.

How do dividend payouts of Alembic Pharmaceuticals Ltd and Sotac Pharmaceuticals Ltd compare?

To compare the dividend payouts of Alembic Pharmaceuticals Ltd and Sotac Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions